Mariam Aghajan

Title: Mariam Aghajan: Innovator in Drug Target Identification

Introduction

Mariam Aghajan is a prominent inventor based in Los Angeles, CA. She has made significant contributions to the field of drug target identification through her innovative methods. Her work focuses on enhancing the efficiency and accuracy of identifying drug targets, which is crucial for the development of effective therapies.

Latest Patents

Mariam Aghajan holds a patent for a method titled "Ligand binding stabilization method for drug target identification." This method, known as Drug Affinity Responsive Target Stability (DARTS), offers several advantages over existing techniques. The process involves contacting a sample containing one or more protein targets with a test agent to create a sample/test agent mixture. This mixture is then treated with a protease, allowing for the identification of proteins or protein fragments that are protected from proteolysis. The protection from proteolysis serves as an indicator that the protein or protein fragment interacts with the test agent. This innovative approach has the potential to streamline drug discovery processes.

Career Highlights

Mariam Aghajan is affiliated with the University of California, where she continues to advance her research in drug target identification. Her work has garnered attention for its practical applications in the pharmaceutical industry. With her expertise, she contributes to the academic community and the broader field of biomedical research.

Collaborations

Mariam collaborates with notable colleagues, including Brett Eugene Lomenick and Jing Huang. These partnerships enhance her research efforts and foster innovation in drug discovery methodologies.

Conclusion

Mariam Aghajan is a trailblazer in the field of drug target identification, with her patented DARTS method representing a significant advancement in the industry. Her contributions are paving the way for more effective drug development strategies.